Jardiance (empagliflozin) is a medicine for type 2 diabetes approved by the FDA in 2014. It is approved to help lower blood sugar levels in adults and children with type 2 diabetes and to lower the ...

The Food and Drug Administration has cleared Boehringer Ingelhein and Lilly’s Jardiance (empagliflozin) 10 mg and 25 mg tablets to lower blood sugar in children 10 years and older with Type 2 diabetes ...

You are able to gift 5 more articles this month. Anyone can access the link you share with no account required. Learn more. DEAR DR. ROACH: I am a 64-year-old male, and my A1C level has been averaging ...

Boehringer Ingelheim and Eli Lilly have received the Food and Drug Administration's green light for Jardiance (empagliflozin) 10 mg tablets to reduce the risk of sustained decline in estimated ...

Yesterday’s FDA approvals of a new indication for empagliflozin and combination empagliflozin with metformin hydrochloride for pediatric type 2 diabetes (T2D) provide a new class of oral drugs to ...

June 20 (Reuters) - The U.S. Food and Drug Administration (FDA) on Tuesday approved Eli Lilly (LLY.N), opens new tab and partner Boehringer Ingelheim's drugs Jardiance and Synjardy to treat type 2 ...